{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:53:59Z","timestamp":1761540839180},"reference-count":34,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T00:00:00Z","timestamp":1207180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> Recombinant activated factor VII (rFVIIa) is an effective treatment of the haemophilia patient with inhibitors and acquired haemophilia. However, on account of its relatively short half\u2010life (HL), achieving therapeutic efficacy with FVIIa requires repeated injections. The development of a long\u2010acting FVIIa product would therefore be beneficial. The formulation of factor VIII with PEGylated liposomes (PEGLip) was previously shown to extend the bleeding\u2010free period in haemophilia patients. We report here an enhancement of haemostatic efficacy by similarly formulating FVIIa with PEGLip. Surface plasmon resonance analysis indicated that FVIIa binds non\u2010covalently but with high affinity and specificity to PEGLip. A one\u2010stage clotting assay demonstrated that formulation of FVIIa with PEGLip does not affect FVIIa activity and stability. A pharmacokinetic study in rats demonstrated that PEGLip formulation of FVIIa extends circulation time and results in higher FVIIa levels several hours after injection. Thromboelastography experiments indicated that PEGLip\u2010FVIIa induces faster clot formation and higher clot stability than standard formulated FVIIa. These results suggest that formulation of FVIIa with PEGLip may lead to a safe and effective long\u2010acting FVIIa that improves the care of haemophilic patients with inhibitors and acquired haemophilia.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2008.01741.x","type":"journal-article","created":{"date-parts":[[2008,4,4]],"date-time":"2008-04-04T06:04:10Z","timestamp":1207289050000},"page":"476-483","source":"Crossref","is-referenced-by-count":28,"title":["Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes"],"prefix":"10.1111","volume":"14","author":[{"given":"R.","family":"YATUV","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"DAYAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"CARMEL\u2010GOREN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"ROBINSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"AVIV","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"GOLDENBERG\u2010FURMANOV","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"BARU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,4,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90259-0"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.00209.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-8463"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615357"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/shem.2001.29507"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2003.11.008"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.80"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbc.0000169218.15926.34"},{"issue":"1","key":"e_1_2_6_10_2","first-page":"S107","article-title":"Home treatment with recombinant activated factor VII: results from one centre","volume":"9","author":"Ingerslev J","year":"1998","journal-title":"Blood Coagul Fibrinol"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615388"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00059.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2003.11.002"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01075.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00032.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1369"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000257204.82396.2b"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06534.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01524.x"},{"issue":"2","key":"e_1_2_6_20_2","first-page":"P\u2010T\u2010012","article-title":"Effect fo glycopegylation\u2122 on the pharmacokineticproperties of FVIIa","volume":"5","author":"Sorensen BB","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"2","key":"e_1_2_6_21_2","first-page":"P\u2010T\u2010016","article-title":"Development of long\u2010acting FVIIa derivatives by glycopegylationTM","volume":"5","author":"Bayer RJ","year":"2007","journal-title":"J Thromb Haemost"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1160\/TH04-08-0485","article-title":"Factor VIII efficient and specific non\u2010covalent binding to PEGylated liposomes enables prolongation of its circulation time and haemostatic efficacy","volume":"93","author":"Baru M","year":"2005","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-008276"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01502.x"},{"key":"e_1_2_6_25_2","first-page":"620","article-title":"Real\u2010time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology","volume":"11","author":"J\u00f6nsson U","year":"1991","journal-title":"BioTechniques"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-200004001-00006"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00528.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-939557"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00075.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05820.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/s-0038-1649605","article-title":"Pharmacokinetics of recombinant factor VIIa in the rat \u2013 a comparison of bio\u2010, immuno\u2010 and isotope assays","volume":"70","author":"Thomsen MK","year":"1993","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb06121.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(94)90227-5"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00242.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2005.11.025"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2008.01741.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2008.01741.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T09:39:20Z","timestamp":1697189960000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2008.01741.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1111\/j.1365-2516.2008.01741.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2008.01741.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,3]]}}}